Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders: Baseline results from the RAISE-ETP Study.
Correll, C.U., Robinson, D.G., Schooler, N.R., Brunette, M.F., Mueser, K.T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S.E., Robinson, J., Penn, D.L., Azrin, S., Goldstein, A., Severe, J., Heinssen, R.K., & Kane, J.M. (2014).
JAMA Psychiatry, 71(12), 1350-1363.